Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-06-08
1998-04-07
Huff, Sheela
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 514 16, 514 15, 530328, 530327, 530326, A61K 3800, C07K 500, C07K 700, C07K 1700
Patent
active
057365172
ABSTRACT:
A method of treating cancer in a human patient, the method involving administering to the patient a cancer cell inhibiting amount of an analog of a naturally occurring biologically active peptide or a fragment thereof, the peptide being one of mammalian gastrin-releasing peptide, neuromedin B, neuromedin C, amphibian bombesin, or litorin.
REFERENCES:
patent: 4321260 (1982-03-01), Auclair
patent: 4473555 (1984-09-01), Nestor et al.
patent: 4569788 (1986-02-01), Mulshine et al.
patent: 4659695 (1987-04-01), Labrie
patent: 4743589 (1988-05-01), Labrie et al.
patent: 4745102 (1988-05-01), Labrie et al.
patent: 4775660 (1988-10-01), Labrie et al.
patent: 5217955 (1993-06-01), Bogden et al.
patent: 5244883 (1993-09-01), Cai et al.
patent: 5428019 (1995-06-01), Edwards et al.
Szepeshazi et al., Dec. 16, 1992, J. Nat'l Cancer Institute (United States), 84 (24) pp. 1915-1922.
Yano et al., Aug. 15, 1992, Cancer Res., vol. 52(16), pp. 4545-4547.
Milovanovic et al., 1992, Prostate vol. 20 (4) pp. 269-280.
Radulovic et al., Nov. 1, 1991, Cancer Res., vol. 51(21) pp. 6006-6009.
Narayan, et al., Feb. 1992, vol. 3 pp. 111-118.
Leban et al., Mar. 1993, Proc. Nat'l Acad. Sci., vol. 90, pp. 1922-1026.
Rivier et al., "Bombesin, Bombesin Analogues, and Related Peptides: Effects on Thermoregulation", 17:1767, 1978.
Cuttitta et al., "Autocrine growth factors in human small cell lung cancer", Cancer Surveys 4:708, 1985.
Zachary et al., "High-affinity receptors for peptides of the bombesin family in Swiss 3T3 cells," Proc. Natl. Acad. Sci. USA, 82:7616, Nov. 1985.
Heinz-Erian et al., "Bombesin analogues: a new class of bombesin receptor antagonists", pp. G439-G442, (1987).
Martinez et al., "Synthesis and Biological Activities of Some Pseudo-Peptide Analogues of Tetragastrin: The Importance of the Peptide Backbone", J. Med. Chem. 1985, 28:1874-1879.
Aumelas et al., ".sup.1 H and .sup.13 C n.m.r. studies of pseudo-peptide analogues of the C-terminal tetrapeptide of gastrin", Int. J. Peptide Protein Res., 1987, 30:596-604.
Dubreuil et al., "Degradation of a Tetragastrin Analogue by a Membrane Fraction from Rat Gastric Mucosa", Drug Design and Delivery, 1987, 2:49-54.
Gargosky et al., "C-Terminal bombesin sequence requirements for binding and effects on protein synthesis in Swiss 3T3 cells", Biochem. J., 1987, 247:427-432.
Heikkila et al., "Bombesin-related peptides Induce Calcium Mobilization in a Subset of Human Small Cell Lung Cancer Cell Lines", The Journal of Biological Chemistry, 1987, 262:16456-16480.
Alexander et al., "Effects of Bombesin on Growth of Human Small Cell Lung Carcinoma in Vivo", Cancer Research, 1988, 48:1439-1441.
Rossowski et al., "Effects of a Novel, Potent Bombesin Antagonist Analogue on Bombesin-Stimulated Gastric Gastric Acid Secretion and Growth Hormone Release in the Pentobarbital-Anesthetized Rat.," 1988 Abstract.
Leij et al. "Recombinant Interleukin-2 Stimulated Lymphocytes in Peripheral Blood as Effector Cells for of Cell Lysis in Small-Cell Lung Carcinoma," 1988, 132:1223.
Heimbrook et al., "Elucidation of a Novel Gastrin Releasing Peptide Antagonist", (to be published in: Synthetic Peptides: Approaches to Biological Problems, vol. 86. (1994).
Woll et al., "Bombesin is a Specific Receptor Antagonist in Swiss 3T3 Cells", Biochemical and Biophysical Research Communications, 1988, 155:359-365.
Caranikas et al., "Synthesis and Biological Activities of Substance P Antagonists", J. Med. Chem. 1982, 25:1313-1316.
Rosell et al., "Substance P-Antagonists: a new type of pharmacological tool", Trends in Pharmacological Sciences 1982, 3:211-212.
Lundberg et al., "A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig", Proc. Natl. Acad. Sci. USA 1983, 80:1120-1124.
Engberg et al., "A synthetic peptide as an antagonist of substance P", Nature 1981, 293:222-223.
Mizrahi et al., "Substance P Antagonists Active in vitro and in vivo", European Journal of Pharmacology, 1982:101-105.
Leander et al., "Aspecific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation", Nature 1981, 294:467-469.
Bogden Arthur E.
Moreau Jacques-Pierre
Biomeasure Inc.
Huff Sheela
LandOfFree
Treatment of cancer with peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of cancer with peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of cancer with peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-13474